AIDS clinical trials /
Other Authors: | , |
---|---|
Format: | Book |
Language: | English |
Published: |
New York :
Wiley-Liss,
[1995]
|
Subjects: |
Table of Contents:
- Introduction
- The natural history of the HIV infection: Implications for clinical trials
- The new drug evaluation process: FDA perspective
- The new drug evaluation process: Industry perspective
- Protocol development
- Data issues in AIDS clinical trials
- Current methods and future trends in the design and analysis of phase I and phase I/II clinical trials in AIDS
- Selection of endpoints for assessment of treatment efficacy in an AIDS trial
- The uses of CD4 lymphocyte count to evaluate therapy for HIV disease
- Sample size calculations for failure time data
- The design and analysis of equivalence trials
- Interim monitoring of clinical trials
- Behavioral science and the design and conduct of randomized AIDS trials
- Compliance in AIDS clinical trials.
- Quality-of-life considerations in AIDS clinical trials
- Issues in analysis of AIDS clinical trials
- Issues in the testing of drug combinations
- Issues in the conduct of clinical trials for HIV-infected children.
- Clinical trials to reduce the risk of maternal-infant transmission of HIV infection
- Obstetrical and gynecological issues in AIDS clinical trials
- Prophylactic HIV vaccine trials
- Large simple trials of HIV therapies
- Economic analysis and AIDS clinical research
- Use of observational data for evaluating AIDS therapies
- Use of cohort studies for evaluating AIDS therapies.